Orpea SA: Post Stabilisation Notice

Orpea SA: Post Stabilisation Notice

Diaxonhit annonce la fusion de ses deux filiales Eurobio et InGen

Diaxonhit annonce la fusion de ses deux filiales Eurobio et InGen

INVENTIVA Announces a U.S. Phase II Investigator-Initiated Study with Lanifibranor on Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes

INVENTIVA Announces a U.S. Phase II Investigator-Initiated Study with Lanifibranor on Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes

CURE Media Group Expands Strategic Alliance Partnership Program with the Head and Neck Cancer Alliance | Business Wire

CURE Media Group Expands Strategic Alliance Partnership Program with the Head and Neck Cancer Alliance | Business Wire: CURE Media Group Expands Strategic Alliance Partnership Program with the Head and Neck Cancer Alliance

Humana Announced as Exclusive Arizona, California, Nevada and Washington Health Plan Sponsor for National Senior Health & Fitness Day®, May 30 | Business Wire

Humana Announced as Exclusive Arizona, California, Nevada and Washington Health Plan Sponsor for National Senior Health & Fitness Day®, May 30 | Business Wire: Humana announced as exclusive Arizona, California, Nevada and Washington health plan sponsor for National Senior Health & Fitness Day, May 30.

Novartis announces JAMA Cardiology publication of data showing Entresto® improves physical and social activity in HFrEF patients versus enalapril

Novartis announces JAMA Cardiology publication of data showing Entresto® improves physical and social activity in HFrEF patients versus enalapril

Acupression pour la douleur menstruelle | EurekAlert! Nouvelles scientifiques

Acupression pour la douleur menstruelle | EurekAlert! Nouvelles scientifiques: Can acupressure achieve a sustained reduction in menstrual pain? Is an app-based self-care program particularly attractive to young women? These questions addressed in a new study by researchers from Charité - Universitätsmedizin Berlin, the results of which have been published in the American Journal of Obstetrics and Gynecology*.

MJ Biotech, Inc Announces $428,000 in First Quarters Sales

MJ Biotech, Inc Announces $428,000 in First Quarters Sales

Cellectar Biosciences Appoints Brian M. Posner as Chief Financial Officer

Cellectar Biosciences Appoints Brian M. Posner as Chief Financial Officer

Cidara Therapeutics to Present Rezafungin Data at the European Congress of Clinical Microbiology and Infectious Diseases 2018 Meeting | Business Wire

Cidara Therapeutics to Present Rezafungin Data at the European Congress of Clinical Microbiology and Infectious Diseases 2018 Meeting | Business Wire: Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that dat

U.S. FDA and European Medicines Agency Accept Regulatory Submissions for Review of Dacomitinib to Treat Metastatic Non-Small Cell Lung Cancer with EGFR-Activating Mutations | Business Wire

U.S. FDA and European Medicines Agency Accept Regulatory Submissions for Review of Dacomitinib to Treat Metastatic Non-Small Cell Lung Cancer with EGFR-Activating Mutations | Business Wire: Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) accepted the company’s New Drug Application and granted priority review f

Tonix Pharmaceuticals to Present FDA Breakthrough Therapy-Designated PTSD Program at the MicroCap Conference in New York

Tonix Pharmaceuticals to Present FDA Breakthrough Therapy-Designated PTSD Program at the MicroCap Conference in New York

NICE rejette Dupixent pour une dermatite atopique pour des raisons de coûts, répond Sanofi | Pharmafile

NICE rejette Dupixent pour une dermatite atopique pour des raisons de coûts, répond Sanofi | Pharmafile

Global Autism Project Partners With Leading Technology and Behavioral Health Experts Rethink

Global Autism Project Partners With Leading Technology and Behavioral Health Experts Rethink

Tilray® Launches High Park Company™ to Produce and Distribute Adult-Use Cannabis in Canada | Business Wire

Tilray® Launches High Park Company™ to Produce and Distribute Adult-Use Cannabis in Canada | Business Wire: Tilray is launching wholly-owned subsidiary High Park to produce and distribute a broad-based portfolio of cannabis brands and products.

Terns Pharmaceuticals获得礼来公司(Eli Lilly and Company)三项NASH资产的全球独家开发和商业化权益 | Business Wire

Terns Pharmaceuticals获得礼来公司(Eli Lilly and Company)三项NASH资产的全球独家开发和商业化权益 | Business Wire: (美国商业资讯) -- Terns Pharmaceuticals Inc.是一家全球性生物制药公司，致力于治疗肝病和癌症的口服小分子创新药物的研发，该公司今天宣布已与礼来公司签署全球性授权协议，获得三个有望用于治疗非酒精性脂肪性肝炎(NASH)的小分子候选药物的全球独家开发和商业化权益。协议包括临

La thérapie par faisceau de protons arrive enfin au Royaume-Uni | Pharmafile

La thérapie par faisceau de protons arrive enfin au Royaume-Uni | Pharmafile

Pfizer à court d'options pour les entreprises de consommation | Pharmafile

Pfizer à court d'options pour les entreprises de consommation | Pharmafile

Helsinn Group and Glenmark Pharmaceuticals enter into an exclusive licensing agreement for launch of AKYNZEO® in India and Nepal

Helsinn Group and Glenmark Pharmaceuticals enter into an exclusive licensing agreement for launch of AKYNZEO® in India and Nepal

IONTAS and IGEM Therapeutics Collaborate to Identify Novel IgE Antibodies for Cancer Targets | Business Wire

IONTAS and IGEM Therapeutics Collaborate to Identify Novel IgE Antibodies for Cancer Targets | Business Wire: IONTAS and IGEM Therapeutics collaborate to identify novel IgE antibodies for cancer targets